This study is completed in the United States. It is testing Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery for depression.
Multiple locations, including Birmingham
Why is this study shown?
This study is directly about Depression.
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 59 Years
This study is looking at whether questionnaires and follow-up can help people with Severe depression, Mental and Behavioural Disorders, or Depression. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is not recruiting in the United Kingdom. It is testing cognitive Behavioural Therapy as an adjunct to pharmacotherapy for treatment-resistant depression.
This observational study is following people with Depression or Mental and Behavioural Disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In Greece
Why is this study shown?
This study is directly about Depression.
DepressionOtherFrom 18 Years to 59 Years
Countries
Greece
Sponsor
First Psychiatry Dept., Eginition Hospital, National and Kapodistrian University of Athens (Greece)
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Estonia
Why is this study shown?
This study is directly about Depression.
DepressionDrugA study involving a medication or substance.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Bulgaria
Why is this study shown?
This study is directly about Depression.
DepressionDrug
Countries
Bulgaria, Finland, Germany
Sponsor
Forest Research Institute, Inc., a wholly owned subsidiary of Forest Laboratories, Inc.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
